Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00003589Phase 3Completed
A Phase 3 trial of paclitaxel, cisplatin, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by European Organisation for Research and Treatment of Cancer. Started Aug 1998; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00003589.